Evidence map›Paper›PMID 41814361›Full record

Trial reportTrials2026

Participant satisfaction across three trial arms with varying degrees of decentralisation in the RADIAL proof-of-concept trial.

Julia Kopanz, Mira G P Zuidgeest, Linda Rutgrink, Cameron Keighron, Diederick E Grobbee, Bart Lagerwaard, Trials@Home consortium

Registry-linked trialAbstract readClinical Trial, Phase IVMulticenter Study
In one paragraph

Trial report in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05780151 (Pan-European Proof-of-concept Study Comparing Decentralised Clinical Trial), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05780151 phase4completednot on this map

Pan-European Proof-of-concept Study Comparing Decentralised Clinical Trial (DCT) and Hybrid Approaches to Conventional Clinical Trial Approaches in Patients With Type 2 Diabetes Mellitus Treated With Toujeo®

TypeinterventionalSponsorMira ZuidgeestRan2023 to 2025Enrolled107ConditionsDiabetes Mellitus, Type 2ArmsMethodological intervention, Toujeo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julia KopanzJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Mira G P ZuidgeestJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. M.G.P.Zuidgeest@umcutrecht.nl.ORCID http://orcid.org/0000-0003-1463-8243
Linda RutgrinkSanofi, Amsterdam, The Netherlands.
Cameron KeighronInternational Diabetes Federation Europe, Brussels, Belgium.
Diederick E GrobbeeJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Bart LagerwaardJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Trials@Home consortium

Funding

Innovative Medicines Initiative 2 Joint Undertaking 831458
6 · The paper itself

Abstract

backgroundAs clinical trials increasingly adopt decentralised elements to potentially reduce burden and enhance participant inclusion, data on participant experience and satisfaction becomes essential to inform future decentralised trial designs. This study investigated participant satisfaction in three trial arms: a fully decentralised arm, a hybrid arm and a conventional arm in individuals with type 2 diabetes mellitus.

methodsRADIAL, a three-arm, low-intervention, phase IV proof-of-concept trial, was set up in six European countries and aimed to evaluate the scientific and operational quality as well as the feasibility of trial approaches with different levels of decentralisation. Participant satisfaction was measured at three time points: at start (week 0), during (week 12), and at the end of the trial (week 24), using digital questionnaires.

resultsIn all arms, 72% to 100% of participants were satisfied with overall trial participation, but satisfaction decreased over time in the hybrid arm compared to the conventional arm. Participants reported issues with trial technologies as reasons for their dissatisfaction in the hybrid arm, which was further substantiated by dissatisfaction with specific digital trial components. Satisfaction with the time commitments and data collection was also lower in the hybrid arm than in the conventional arm. Nevertheless, participants in both arms were very satisfied with the comprehensibility of the information before trial start, feeling of safety, interaction with trial staff, and timing of trial appointments, ranging from 92% to 100%. Due to the small number of seven participants in the remote arm, no meaningful conclusions on satisfaction could be drawn in this arm.

conclusionsDecentralisation seems to be acceptable to trial participants, as trial activities can be responsibly shifted from the research site to participants' homes, e.g. decentralised, without materially impacting participant satisfaction. However, technological issues negatively affected satisfaction in the hybrid arm, highlighting the need to utilise fit-for-purpose technologies and adequately address potential digital challenges in trials. Including participant satisfaction measures in trials deepens the understanding of how participants experience different (decentralised) trial activities, which can help to tailor future trials to their needs.

trial registrationClinicalTrials.gov NCT05780151 (2023-03-08) and CTIS 2022-500,449-26-00 (2022-03-28).

Indexed as

Diabetes Mellitus, Type 2Patient SatisfactionAgedEuropeFemaleHumansMaleMiddle AgedProof of Concept StudyResearch DesignSurveys and QuestionnairesTime FactorsDecentralised clinical trialHybrid trialParticipant satisfactionTrial experienceTrial innovation

Identifiers

PMID41814361
PMCPMC13094246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.